Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Development of a High-Throughput Screening Assay with Nurse-like Cell-Based Microenviroment in Chronic Lymphoid Leukemia Cells.

Blood (2014) 124 (21): 3639.

https://doi.org/10.1182/blood.V124.21.3639.3639

Published: 2014

Journal Articles

Novel Assay for Ex Vivo Evaluation of Antiproliferative Effect of Hypomethylating Agents 5-Azacytidine and Decitabine in AML Patient Samples

Pilar Hernandez, PhD, Pau Montesinos, MD, Josefina Serrano, MD, Pilar Herrera, MD, Juan Pedro Bergua, MD, Mercedes Colorado, MD, Bernando J Gonzalez, MD, Cristina Gomez, Alicia Robles, Julian Gorrochategui, Jesus Sanchez, Joan Ballesteros, PhD, Federico Moscardo, MD, David Martinez, MD, Miguel Angel Sanz, MD, Jaime Pérez de Oteyza, MD, Joaquin Martinez, MD

Blood (2014) 124 (21): 5311.

https://doi.org/10.1182/blood.V124.21.5311.5311

Published: 2014

Journal Articles

Novel Ex Vivo Assay Measures Drug-Induced Depletion of Hematopoietic Progenitors As an Estimate of Hematotoxicity

Blood (2014) 124 (21): 5785.

https://doi.org/10.1182/blood.V124.21.5785.5785

Published: 2014

Journal Articles

Maintenance Therapy After Stem-Cell Transplantation for Multiple Myeloma with Bortezomib/Thalidomide Vs. Thalidomide Vs. alfa2b-Interferon: Final Results of a Phase III Pethema/GEM Randomized Trial

Blood (2012) 120 (21): 334.

https://doi.org/10.1182/blood.V120.21.334.334

Published: 2012

Journal Articles

Inhibition of Related JAK/STAT Pathways with Molecular Targeted Drugs Shows Strong Synergy with Ruxolitinib in Chronic Myeloproliferative Neoplasms

Santiago Barrio, Miguel Gallardo, Alicia Arenas, Rosa M. Ayala, MD, PhD, Inmaculada Rapado, Daniel Rueda, PhD, Ana Jimenez, Enriqueta Albizua, Carmen Burgaleta, Florinda Gilsanz, MD, PhD, Joaquin Martinez, MD

Blood (2012) 120 (21): 5054.

https://doi.org/10.1182/blood.V120.21.5054.5054

Published: 2012

Journal Articles

Personalized Treatment with low doses of Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma in frail or Elderly Patients

Angel Ruedas, MD, Pablo Guisado, MD, PhD, Beatriz Aguado, MD, PhD, Ricardo Perez, MD, Joaquin Martinez, MD, J Valentin Garcia-Gutierrez, MD, PhD, M. Jesús Blanchard, MD, Pilar Bravo, MD, Carlos Montalban

Blood (2012) 120 (21): 5049.

https://doi.org/10.1182/blood.V120.21.5049.5049

Published: 2012

Journal Articles

Outcomes of Chronic Myeloid Leukemia (CML) Patients Who Stopped Second Generation Tyrosine Kinase Inhibitors (2GTKIs) As Second Line Treatment. Results of the CML Spanish National Registry (RELMC)

J Valentin Garcia-Gutierrez, MD, PhD, Begoña Maestro, Luis Felipe Casado, MD, PhD, Manuel Perez-Encinas, Isabel Massague, Raquel de Paz, Santiago Osorio, Joaquin Martinez, MD, Guiomar Bautista, MD, Pilar Giraldo, Carmen Burgaleta, Maria Jesús Peñarrubia, Maria José Requena, Carmen Calle, Jose Ángel Hernández-Rivas, Pilar Cano, Juan Luis Steegmann, MD, PhD

Blood (2012) 120 (21): 3764.

https://doi.org/10.1182/blood.V120.21.3764.3764

Published: 2012

Journal Articles

Switching to a Second Generation TKI in Chronic Myeloid Leukemia Patients with Late Suboptimal Response with Imatinib Obtained Better Molecular Responses That the “Watch and Wait” Approach. an Experience of a Multicenter Registry in Patients Outside Clinical Trials

J Valentin Garcia-Gutierrez, MD, PhD, Begoña Maestro, Luis Felipe Casado, MD, PhD, Manuel Perez-Encinas, Isabel Massague, Raquel De Paz, MD, Santiago Osorio, Joaquin Martinez, MD, Guiomar Bautista, MD, Pilar Giraldo, Carmen Burgaleta, Maria Jesús Peñarrubia, Maria José Requena, Carmen Calle, Jose Angel Hernandez-rivas, MD, Pilar Cano, Juan Luis Steegmann, MD, PhD

Blood (2012) 120 (21): 3768.

https://doi.org/10.1182/blood.V120.21.3768.3768

Published: 2012

Journal Articles

A Phase III PETHEMA/GEM Randomized Trial of Postransplant (ASCT) Maintenance in Multiple Myeloma: Superiority of Bortezomib/Thalidomide Compared with Thalidomide and Alfa-2b Interferon,

Blood (2011) 118 (21): 3962.

https://doi.org/10.1182/blood.V118.21.3962.3962

Published: 2011

Journal Articles

Multidimensional Flow Cytometric (MFC) Analysis of the Immune System of Multiple Myeloma (MM) Patients Achieving Long Term Disease Control

Roberto J. Pessoa Magalhaes, María-Belén Vidriales, Bruno Paiva, Maria-Victoria Mateos, Norma C. Gutierrez, Ramón García-Sanz, Juan F Blanco, Jose Hernández, Natalia de las Heras, Joaquin Martinez, MD, Elaine Sobral Costa, MD, PhD, Angelo Maiolino, MD, PhD, M. Nucci, MD, PhD, Javier De La Rubia, Juan-Jose Lahuerta, MD, Alberto Orfao, MD, PhD, Jesús F. San Miguel, Sr., MD, PhD

Blood (2011) 118 (21): 810.

https://doi.org/10.1182/blood.V118.21.810.810

Published: 2011

Journal Articles

Efficacy of Lenalidomide-Based Regimens in Multiple Myeloma Complicated by Extramedullary Plasmacytomas at Relapse or Progression.

Jose Manuel Calvo-Villas, MD, Adrian Alegre, MD, Ricarda García-Sánchez, MD, Miguel T Hernández, MD, Pilar Giraldo, MD, Maite Zudaire, MD, Bremo Gusmao, MD, Juan N Rodríguez, MD, Carmen Calle, MD, Gemma Ramirez, MD, Belen Iñigo, MD, Joaquin Martinez, MD, Albert Oriol, MD

Blood (2009) 114 (22): 4952.

https://doi.org/10.1182/blood.V114.22.4952.4952

Published: 2009

Journal Articles

Tailored Low Dose Lenalidomide with Low Dose Dexamethasone (len/dex) in Previously Treated Patients with Multiple Myeloma Older Than 70 Years Requiring Treatment.

Angel Ruedas, MD, Ricardo Perez, MD, Valentin Garcia, MD, Alicia Smucler, MD, Pilar Bravo, MD, Joaquin Martinez, MD, Pilar Sabin, MD, Pablo Guisado, MD, PhD, Carlos Montalban, PHD

Blood (2009) 114 (22): 4950.

https://doi.org/10.1182/blood.V114.22.4950.4950

Published: 2009

Journal Articles

A Prospective, Multicenter, Randomized, Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone (VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT) Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple Myeloma Older Than 65 Years.

Blood (2009) 114 (22): 3.

https://doi.org/10.1182/blood.V114.22.3.3

Published: 2009

Journal Articles

Long-Term Follow-up of Donor Chimerism and Tolerance After Human Liver Transplantation.

Silvia Grande, Rosa Maria Ayala Diaz, MD, PhD, Florinda Gilsanz, MD, PhD, Enrique Moreno, Joaquin Martinez, MD

Blood (2009) 114 (22): 3534.

https://doi.org/10.1182/blood.V114.22.3534.3534

Published: 2009

Journal Articles

Discrepancy between Phenotype and Genotype for Factor V Leiden Mutation in Recipients of Liver Transplant.

Rosa M. Ayala, MD, Maria Angeles Martin, MD, Joaquin Martinez, MD, Juan Carlos Meneu, MD, Almudena Moreno, MD, Teresa Toledo, MD, Javier De la Serna, MD, Carmen Ribera, MD

Blood (2005) 106 (11): 4120.

https://doi.org/10.1182/blood.V106.11.4120.4120

Published: 2005

Journal Articles

The Role of a Thrombofilia Screening in Prospective Liver Donors (LDLT, Live Donor Liver Transplant).

Rosa M. Ayala, MD, Angeles M. Martin, MD, Joaquin Martinez, MD, Juan Carlos Meneu, MD, Almudena Moreno, MD, Teresa Toledo, MD, Javier De la Serna, MD, Carmen Ribera, MD

Blood (2005) 106 (11): 4125.

https://doi.org/10.1182/blood.V106.11.4125.4125

Published: 2005

NARROW

Development of a High-Throughput Screening Assay with Nurse-like Cell-Based Microenviroment in Chronic Lymphoid Leukemia Cells.

Novel Assay for Ex Vivo Evaluation of Antiproliferative Effect of Hypomethylating Agents 5-Azacytidine and Decitabine in AML Patient Samples

Novel Ex Vivo Assay Measures Drug-Induced Depletion of Hematopoietic Progenitors As an Estimate of Hematotoxicity

Maintenance Therapy After Stem-Cell Transplantation for Multiple Myeloma with Bortezomib/Thalidomide Vs. Thalidomide Vs. alfa2b-Interferon: Final Results of a Phase III Pethema/GEM Randomized Trial

Inhibition of Related JAK/STAT Pathways with Molecular Targeted Drugs Shows Strong Synergy with Ruxolitinib in Chronic Myeloproliferative Neoplasms

Personalized Treatment with low doses of Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma in frail or Elderly Patients

Outcomes of Chronic Myeloid Leukemia (CML) Patients Who Stopped Second Generation Tyrosine Kinase Inhibitors (2GTKIs) As Second Line Treatment. Results of the CML Spanish National Registry (RELMC)

Switching to a Second Generation TKI in Chronic Myeloid Leukemia Patients with Late Suboptimal Response with Imatinib Obtained Better Molecular Responses That the “Watch and Wait” Approach. an Experience of a Multicenter Registry in Patients Outside Clinical Trials

A Phase III PETHEMA/GEM Randomized Trial of Postransplant (ASCT) Maintenance in Multiple Myeloma: Superiority of Bortezomib/Thalidomide Compared with Thalidomide and Alfa-2b Interferon,

Multidimensional Flow Cytometric (MFC) Analysis of the Immune System of Multiple Myeloma (MM) Patients Achieving Long Term Disease Control

Efficacy of Lenalidomide-Based Regimens in Multiple Myeloma Complicated by Extramedullary Plasmacytomas at Relapse or Progression.

Tailored Low Dose Lenalidomide with Low Dose Dexamethasone (len/dex) in Previously Treated Patients with Multiple Myeloma Older Than 70 Years Requiring Treatment.

Long-Term Follow-up of Donor Chimerism and Tolerance After Human Liver Transplantation.

Discrepancy between Phenotype and Genotype for Factor V Leiden Mutation in Recipients of Liver Transplant.

The Role of a Thrombofilia Screening in Prospective Liver Donors (LDLT, Live Donor Liver Transplant).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only